JAK Inhibitors for Rheumatoid Arthritis
This 2023 review article provides a comprehensive overview of Janus kinase (JAK) inhibitors in the treatment of rheumatoid arthritis (RA). It discusses the mechanisms by which JAK inhibitors modulate the JAK-STAT signaling pathway to reduce inflammation and halt disease progression. The article evaluates the efficacy and safety profiles of various
June 26, 2025
No Comments